Viewing Study NCT05432635


Ignite Creation Date: 2025-12-24 @ 10:36 PM
Ignite Modification Date: 2025-12-28 @ 5:20 AM
Study NCT ID: NCT05432635
Status: RECRUITING
Last Update Posted: 2025-02-18
First Post: 2022-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module